research
Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.
- Publication date
- 1 January 2014
- Publisher
- 'Springer Science and Business Media LLC'